Sign Up to like & get
recommendations!
1
Published in 2019 at "Archiv der Pharmazie"
DOI: 10.1002/ardp.201900177
Abstract: No drug has been approved to prevent neuronal cell loss in patients suffering from Parkinson's disease (PD) or Alzheimer's disease (AD); despite increased comprehension of the underlying molecular causes, therapies target cognitive functional improvement and…
read more here.
Keywords:
acting mao;
emerging therapeutic;
dual acting;
drug ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "European journal of medicinal chemistry"
DOI: 10.1016/j.ejmech.2018.09.043
Abstract: A series of compounds containing pyrrolidine and pyrrolizidine cores with appended hydrophobic substituents were prepared as constrained analogs of FTY720 and phytosphingosine. The effect of these compounds on the viability of cancer cells, on downregulation…
read more here.
Keywords:
analogs dual;
phytosphingosine analogs;
fty720 phytosphingosine;
dual acting ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
2
Published in 2022 at "ACS Medicinal Chemistry Letters"
DOI: 10.1021/acsmedchemlett.2c00160
Abstract: The free fatty acid receptors FFAR1 and FFAR4 are considered promising therapeutic targets for management of metabolic and inflammatory diseases. However, there is a need for entirely novel chemical scaffolds, since many of the highly…
read more here.
Keywords:
optimization first;
first class;
dual acting;
ffar1 ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "ACS Omega"
DOI: 10.1021/acsomega.2c01667
Abstract: Biofilms facilitate the pathogenesis of life-threatening Pseudomonas aeruginosa infections by coating mucosal surfaces or invasive devices and offer protection from antimicrobial therapy and the host immune response, thus increasing mortality rates and financial burden. Herein,…
read more here.
Keywords:
acting matrix;
hybrid acylcysteines;
pseudomonas aeruginosa;
dual acting ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2020 at "Scientific Reports"
DOI: 10.1038/s41598-020-69614-7
Abstract: Recombinant interferon-α (IFN-α) treatment functionally cures chronic hepatitis B virus (HBV) infection in some individuals and suppresses virus replication in hepatocytes infected in vitro. We studied the antiviral effect of conditioned media (CM) from peripheral…
read more here.
Keywords:
toll like;
dual acting;
hbv;
agonists potent ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2022 at "Oncoimmunology"
DOI: 10.1080/2162402x.2022.2028961
Abstract: ABSTRACT Targeting costimulatory receptors of the tumor necrosis factor superfamily (TNFSF) to activate T-cells and promote anti-tumor T-cell function have emerged as a promising strategy in cancer immunotherapy. Previous studies have shown that combining two…
read more here.
Keywords:
cell;
dual acting;
single chain;
acting costimulatory ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Antibiotics"
DOI: 10.3390/antibiotics10050489
Abstract: In the current work, in continuation of our recent research, we synthesized and studied new chimeric compounds, including the ribosome-targeting antibiotic chloramphenicol (CHL) and the membrane-penetrating cation triphenylphosphonium (TPP), which are linked by alkyl groups…
read more here.
Keywords:
analogs chloramphenicol;
cam;
cam tpp;
dual acting ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2022 at "Biomolecules"
DOI: 10.3390/biom12030448
Abstract: Aldose reductase (ALR2) is the enzyme in charge of developing cellular toxicity caused by diabetic hyperglycemia, which in turn leads to the generation of reactive oxygen species triggering oxidative stress. Therefore, inhibiting ALR2 while pursuing…
read more here.
Keywords:
oxidative stress;
dual acting;
acting;
aldose reductase ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms231911452
Abstract: This study aimed to extend the body of preclinical research on prototype dual-acting compounds combining the pharmacophores relevant for inhibiting cyclic nucleotide phosphodiesterase 10 (PDE10A) and serotonin 5-HT1A/5-HT7 receptor (5-HT1AR/5-HT7R) activity into a single chemical…
read more here.
Keywords:
administration;
antidepressant like;
pqa;
pqa az6 ... See more keywords